June 14, 9:03 PMVaccines ExaminerNorma Erickson
Part of the World Health Organization’s mandate is to provide guidance to member nations on health policy matters, including vaccinations. On the 10th of April 2009, they published their first official position paper regarding vaccines against diseases caused by human papillomaviruses (HPVs). The information provided in this paper is primarily concerned with large-scale immunization programs, such as the one recently called to a halt in India.
The information contained in WHO’s position paper has been reviewed and endorsed by a number of experts within and outside the organization, including SAGE, WHO’s Strategic Advisory Group of Experts on vaccines and immunizations.
Human papillomavirus vaccines WHO position paper was primarily designed to provide guidance to national public health officials and managers of immunization programmes around the world. It was also published to give helpful information to international funding agencies, vaccine manufacturers, medical and scientific communities, and the general public. In other words, this document was designed as an aid to everyone involved in vaccination programs, from manufacturer to consumer.
Take a look at the following statements from WHO’s HPV vaccines position paper and compare them to what you observe happening around the world. Decide for yourself whether what is going on makes any sense when events are examined in light of the information vaccine experts from around the world have put forth in this document.